Neuromyelitis optica is an HLA associated disease different from Multiple Sclerosis: a systematic review with meta-analysis

Abstract Neuromyelitis Optica and Multiple Sclerosis are idiopathic inflammatory demyelinating diseases of the central nervous system that currently are considered distinct autoimmune diseases, so differences in genetic susceptibility would be expected. This study aimed to investigate the HLA associ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marcos Papais Alvarenga, Luciana Ferreira do Carmo, Claudia Cristina Ferreira Vasconcelos, Marina Papais Alvarenga, Helcio Alvarenga-Filho, Cleonice Alves de Melo Bento, Carmen Lucia Antão Paiva, Laura Leyva-Fernández, Óscar Fernández, Regina Maria Papais-Alvarenga
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/780a5ddcc22b4e3ea7650035a82f2f45
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:780a5ddcc22b4e3ea7650035a82f2f45
record_format dspace
spelling oai:doaj.org-article:780a5ddcc22b4e3ea7650035a82f2f452021-12-02T15:12:52ZNeuromyelitis optica is an HLA associated disease different from Multiple Sclerosis: a systematic review with meta-analysis10.1038/s41598-020-80535-32045-2322https://doaj.org/article/780a5ddcc22b4e3ea7650035a82f2f452021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-80535-3https://doaj.org/toc/2045-2322Abstract Neuromyelitis Optica and Multiple Sclerosis are idiopathic inflammatory demyelinating diseases of the central nervous system that currently are considered distinct autoimmune diseases, so differences in genetic susceptibility would be expected. This study aimed to investigate the HLA association with Neuromyelitis Optica by a systematic review with meta-analysis. The STROBE instrument guided research paper assessments. Thirteen papers published between 2009 and 2020 were eligible. 568 Neuromyelitis Optica patients, 41.4% Asians, 32.4% Latin Americans and 26.2% Europeans were analyzed. Only alleles of the DRB1 locus were genotyped in all studies. Neuromyelitis Optica patients have 2.46 more chances of having the DRB1*03 allelic group than controls. Ethnicity can influence genetic susceptibility. The main HLA association with Neuromyelitis Optica was the DRB1*03:01 allele in Western populations and with the DPB1*05:01 allele in Asia. Differences in the Multiple Sclerosis and Neuromyelitis Optica genetic susceptibility was confirmed in Afro descendants. The DRB1*03 allelic group associated with Neuromyelitis Optica has also been described in other systemic autoimmune diseases.Marcos Papais AlvarengaLuciana Ferreira do CarmoClaudia Cristina Ferreira VasconcelosMarina Papais AlvarengaHelcio Alvarenga-FilhoCleonice Alves de Melo BentoCarmen Lucia Antão PaivaLaura Leyva-FernándezÓscar FernándezRegina Maria Papais-AlvarengaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Marcos Papais Alvarenga
Luciana Ferreira do Carmo
Claudia Cristina Ferreira Vasconcelos
Marina Papais Alvarenga
Helcio Alvarenga-Filho
Cleonice Alves de Melo Bento
Carmen Lucia Antão Paiva
Laura Leyva-Fernández
Óscar Fernández
Regina Maria Papais-Alvarenga
Neuromyelitis optica is an HLA associated disease different from Multiple Sclerosis: a systematic review with meta-analysis
description Abstract Neuromyelitis Optica and Multiple Sclerosis are idiopathic inflammatory demyelinating diseases of the central nervous system that currently are considered distinct autoimmune diseases, so differences in genetic susceptibility would be expected. This study aimed to investigate the HLA association with Neuromyelitis Optica by a systematic review with meta-analysis. The STROBE instrument guided research paper assessments. Thirteen papers published between 2009 and 2020 were eligible. 568 Neuromyelitis Optica patients, 41.4% Asians, 32.4% Latin Americans and 26.2% Europeans were analyzed. Only alleles of the DRB1 locus were genotyped in all studies. Neuromyelitis Optica patients have 2.46 more chances of having the DRB1*03 allelic group than controls. Ethnicity can influence genetic susceptibility. The main HLA association with Neuromyelitis Optica was the DRB1*03:01 allele in Western populations and with the DPB1*05:01 allele in Asia. Differences in the Multiple Sclerosis and Neuromyelitis Optica genetic susceptibility was confirmed in Afro descendants. The DRB1*03 allelic group associated with Neuromyelitis Optica has also been described in other systemic autoimmune diseases.
format article
author Marcos Papais Alvarenga
Luciana Ferreira do Carmo
Claudia Cristina Ferreira Vasconcelos
Marina Papais Alvarenga
Helcio Alvarenga-Filho
Cleonice Alves de Melo Bento
Carmen Lucia Antão Paiva
Laura Leyva-Fernández
Óscar Fernández
Regina Maria Papais-Alvarenga
author_facet Marcos Papais Alvarenga
Luciana Ferreira do Carmo
Claudia Cristina Ferreira Vasconcelos
Marina Papais Alvarenga
Helcio Alvarenga-Filho
Cleonice Alves de Melo Bento
Carmen Lucia Antão Paiva
Laura Leyva-Fernández
Óscar Fernández
Regina Maria Papais-Alvarenga
author_sort Marcos Papais Alvarenga
title Neuromyelitis optica is an HLA associated disease different from Multiple Sclerosis: a systematic review with meta-analysis
title_short Neuromyelitis optica is an HLA associated disease different from Multiple Sclerosis: a systematic review with meta-analysis
title_full Neuromyelitis optica is an HLA associated disease different from Multiple Sclerosis: a systematic review with meta-analysis
title_fullStr Neuromyelitis optica is an HLA associated disease different from Multiple Sclerosis: a systematic review with meta-analysis
title_full_unstemmed Neuromyelitis optica is an HLA associated disease different from Multiple Sclerosis: a systematic review with meta-analysis
title_sort neuromyelitis optica is an hla associated disease different from multiple sclerosis: a systematic review with meta-analysis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/780a5ddcc22b4e3ea7650035a82f2f45
work_keys_str_mv AT marcospapaisalvarenga neuromyelitisopticaisanhlaassociateddiseasedifferentfrommultiplesclerosisasystematicreviewwithmetaanalysis
AT lucianaferreiradocarmo neuromyelitisopticaisanhlaassociateddiseasedifferentfrommultiplesclerosisasystematicreviewwithmetaanalysis
AT claudiacristinaferreiravasconcelos neuromyelitisopticaisanhlaassociateddiseasedifferentfrommultiplesclerosisasystematicreviewwithmetaanalysis
AT marinapapaisalvarenga neuromyelitisopticaisanhlaassociateddiseasedifferentfrommultiplesclerosisasystematicreviewwithmetaanalysis
AT helcioalvarengafilho neuromyelitisopticaisanhlaassociateddiseasedifferentfrommultiplesclerosisasystematicreviewwithmetaanalysis
AT cleonicealvesdemelobento neuromyelitisopticaisanhlaassociateddiseasedifferentfrommultiplesclerosisasystematicreviewwithmetaanalysis
AT carmenluciaantaopaiva neuromyelitisopticaisanhlaassociateddiseasedifferentfrommultiplesclerosisasystematicreviewwithmetaanalysis
AT lauraleyvafernandez neuromyelitisopticaisanhlaassociateddiseasedifferentfrommultiplesclerosisasystematicreviewwithmetaanalysis
AT oscarfernandez neuromyelitisopticaisanhlaassociateddiseasedifferentfrommultiplesclerosisasystematicreviewwithmetaanalysis
AT reginamariapapaisalvarenga neuromyelitisopticaisanhlaassociateddiseasedifferentfrommultiplesclerosisasystematicreviewwithmetaanalysis
_version_ 1718387639205232640